Global Heavy Ion Therapy Technology Market Growth (Status and Outlook) 2025-2031

The global Heavy Ion Therapy Technology market size is predicted to grow from US$ 91.7 million in 2025 to US$ 295 million in 2031; it is expected to grow at a CAGR of 21.5% from 2025 to 2031.

One of the newer types of RT treatment uses protons or heavier ions. Unlike X-rays, protons (and heavier charged particles) deliver most of their dose in a well-defined Bragg peak. This allows more dose to be delivered to the tumour whilst sparing the healthy tissues, surrounding it. In particular, for protons, there is no exit dose beyond the target. For heavier charged particles, a fragmentation tail is observed and this is part of the reason why proton beam therapy (PBT) is considered preferable for treating childhood cancers, through reduced effects on growth, organ function and second malignancy risk later in life. Charged particle beams also offer the potential for treating tumours which lie close to critical organs, such as the brain or spinal cord. Heavier ions, such as carbon, have a substantially smaller (sharper) penumbra, potentially providing a significant advantage in this setting.

In recent years, with the advancement of medical technology, the scale of the heavy particles therapy market has gradually expanded, which has driven the growth of demand for heavy particles therapy equipment in the market. This report focuses on the heavy particle therapy technology devices market.

In conventional heavy-particle radiotherapy equipment, only carbon ions are used. In multi-ion therapy, on the other hand, various kinds of ion beams—optimal for the specific malignancy—are combined to kill more cancer cells with fewer side effects. In 2022, QST and SHI succeeded in creating a multi-ion source, using neon, oxygen, and helium ions among others, making multi-ion radiotherapy possible. The system was installed at QST’s Heavy Ion Medical Accelerator in Chiba (HIMAC) for further research. With the new system, oxygen, heavier than carbon, was irradiated to the center of a tumor, and helium, lighter than carbon, was irradiated to an area nearer to normal tissue.

Through a comparison with cases where only carbon ions were irradiated, it was confirmed that using different ion beams was more effective. In surgical treatments for sarcoma, depending on the site of the operation, patients often experience nerve injuries (neuropathy). Satisfactory results have been obtained using heavy ions, even for those patients for whom surgery would not have been possible. Moreover, in treatments of very large tumors, recurrence has been a frequent problem. The first case using multi-ion therapy occurred in November and December 2023, involving irradiation applied on the same patient 16 times. For the first time, carbon and oxygen irradiations were done on the same day, and switching between them was conducted smoothly. The patient was discharged the day after the treatments ended, and no early side effects were seen two months later.

ReportPrime' newest research report, the “Heavy Ion Therapy Technology Industry Forecast” looks at past sales and reviews total world Heavy Ion Therapy Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Heavy Ion Therapy Technology sales for 2025 through 2031. With Heavy Ion Therapy Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heavy Ion Therapy Technology industry.

This Insight Report provides a comprehensive analysis of the global Heavy Ion Therapy Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Heavy Ion Therapy Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heavy Ion Therapy Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heavy Ion Therapy Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heavy Ion Therapy Technology.

This report presents a comprehensive overview, market shares, and growth opportunities of Heavy Ion Therapy Technology market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Heavy Ion Therapy System
• Protons Therapy System
• Others

Segmentation by Application:

• Hospital
• Research Institute

Market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Company’s coverage:

• Toshiba
• Hitachi
• Lanzhou Ion Therapy Co., Ltd.
• CAS Ion Medical Technology Co., Ltd. (CASHIM)
• Sumitomo Heavy Industries (SHI)
• Siemens
• Mevion
• Varian Medical Systems, Inc.

Key Questions Addressed in this Report: